Correlation of CTNNB1 mutation status with progression arrest rate in RECIST progressive desmoid-type fibromatosis treated with imatinib: translational research results from a phase 2 study of the german interdisciplinary sarcoma group (GISG-01)

Annals of Surgical Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/24FCfkw
via IFTTT